Metabolic Comparison

Semaglutide vs Liraglutide

Comparison of two FDA-approved GLP-1 agonists for diabetes and weight management.

Last updated: January 19, 2026

Semaglutide

High Evidence
View full dossier

Liraglutide

High Evidence
View full dossier

Overview

Both are FDA-approved GLP-1 agonists from Novo Nordisk, but semaglutide offers greater efficacy and less frequent dosing.

Key Differences

AspectSemaglutideLiraglutide
Max Weight Loss~15% (STEP)~8% (SCALE)
CV OutcomesSELECT positiveLEADER positive

Efficacy Comparison

MetricSemaglutide 2.4mgLiraglutide 3.0mg
Weight Loss14.9%8.0%
HbA1c (T2D)SuperiorEstablished
CV Benefit20% MACE reduction13% MACE reduction

Convenience

Semaglutide’s once-weekly dosing offers significant convenience advantage over daily liraglutide injections.

Summary

  • Semaglutide: More effective, less frequent dosing
  • Liraglutide: First-in-class, longer track record
  • Both have established efficacy and CV benefits

This comparison is for educational purposes only. Both medications require a prescription.

Stay Updated on Peptide Comparisons

Get notified when we publish new comparison dossiers and evidence reviews.

No spam. Unsubscribe anytime.

Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.